Retinopathy of prematurity

David K. Coats; Ashvini K. Reddy

doi:10.1007/978-3-540-68632-3_25

Retinopathy of prematurity

David K. Coats, Ashvini K. Reddy

Research output: Chapter in Book/Report/Conference proceeding › Chapter

3 Scopus citations

Abstract

The search for a cure for retinopathy of prematurity (ROP) has become a priority among researchers since the disease was first described by Theodore L. Terry in 1942 [68]. ROP is a common disorder, and the risk of visual impairment can be minimized in the vast majority of affected infants with careful management. Despite this, it is estimated that ROP accounts for 19% of cases of pediatric blindness worldwide [29] and is a leading cause of blindness in children attending schools for the blind [63, 66]. Continued interest in understanding and eradicating the disorder has brought about unprecedented collaboration among scientists, ophthalmologists, and public health activists in both developed and developing nations.

Original language	English (US)
Title of host publication	Pediatric Ophthalmology
Subtitle of host publication	Current Thought and A Practical Guide
Publisher	Springer Berlin Heidelberg
Pages	375-386
Number of pages	12
ISBN (Print)	9783540686309
DOIs	https://doi.org/10.1007/978-3-540-68632-3_25
State	Published - 2009
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-3-540-68632-3_25

Fingerprint Dive into the research topics of 'Retinopathy of prematurity'. Together they form a unique fingerprint.

Cite this

@inbook{e80078647a1e4d36b7fae9655d1fc3b2,

title = "Retinopathy of prematurity",

abstract = "The search for a cure for retinopathy of prematurity (ROP) has become a priority among researchers since the disease was first described by Theodore L. Terry in 1942 [68]. ROP is a common disorder, and the risk of visual impairment can be minimized in the vast majority of affected infants with careful management. Despite this, it is estimated that ROP accounts for 19% of cases of pediatric blindness worldwide [29] and is a leading cause of blindness in children attending schools for the blind [63, 66]. Continued interest in understanding and eradicating the disorder has brought about unprecedented collaboration among scientists, ophthalmologists, and public health activists in both developed and developing nations.",

author = "Coats, {David K.} and Reddy, {Ashvini K.}",

year = "2009",

doi = "10.1007/978-3-540-68632-3_25",

language = "English (US)",

isbn = "9783540686309",

pages = "375--386",

booktitle = "Pediatric Ophthalmology",

publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Retinopathy of prematurity

AU - Coats, David K.

AU - Reddy, Ashvini K.

PY - 2009

Y1 - 2009

N2 - The search for a cure for retinopathy of prematurity (ROP) has become a priority among researchers since the disease was first described by Theodore L. Terry in 1942 [68]. ROP is a common disorder, and the risk of visual impairment can be minimized in the vast majority of affected infants with careful management. Despite this, it is estimated that ROP accounts for 19% of cases of pediatric blindness worldwide [29] and is a leading cause of blindness in children attending schools for the blind [63, 66]. Continued interest in understanding and eradicating the disorder has brought about unprecedented collaboration among scientists, ophthalmologists, and public health activists in both developed and developing nations.

AB - The search for a cure for retinopathy of prematurity (ROP) has become a priority among researchers since the disease was first described by Theodore L. Terry in 1942 [68]. ROP is a common disorder, and the risk of visual impairment can be minimized in the vast majority of affected infants with careful management. Despite this, it is estimated that ROP accounts for 19% of cases of pediatric blindness worldwide [29] and is a leading cause of blindness in children attending schools for the blind [63, 66]. Continued interest in understanding and eradicating the disorder has brought about unprecedented collaboration among scientists, ophthalmologists, and public health activists in both developed and developing nations.

UR - http://www.scopus.com/inward/record.url?scp=80051965280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051965280&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-68632-3_25

DO - 10.1007/978-3-540-68632-3_25

M3 - Chapter

AN - SCOPUS:80051965280

SN - 9783540686309

SP - 375

EP - 386

BT - Pediatric Ophthalmology

PB - Springer Berlin Heidelberg

ER -